Covered recipient · General Payments record
NICKISA HODGSON
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2022–2024
$1,991.75
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $400.28 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $310.81 | 8 |
| Coherus Biosciences Inc. | $36.14 | 1 |
| Apellis Pharmaceuticals, Inc. | $31.83 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.21 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724167 | CMS |
| Amgen Inc. | $8.53 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724176 | CMS |
| Amgen Inc. | $19.99 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724181 | CMS |
| Amgen Inc. | $5.50 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724190 | CMS |
| Amgen Inc. | $19.62 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724198 | CMS |
| Amgen Inc. | $20.51 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724206 | CMS |
| Amgen Inc. | $70.35 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724212 | CMS |
| Amgen Inc. | $147.10 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724218 | CMS |
| Apellis Pharmaceuticals, Inc. | $31.83 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154027195 | CMS |
| Coherus Biosciences Inc. | $36.14 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147274112 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.50 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152187773 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.